Meningococcal infections.
D000372:Agglutination Tests; D001431:Bacteriological Techniques; D002353:Carrier State; D004739:England; D006801:Humans; D007114:Immunization; D008589:Meningococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000276:immunology / Q000517:prevention & control; D009305:Nasopharynx / Q000382:microbiology; D009345:Neisseria meningitidis / Q000302:isolation & purification; D009426:Netherlands; D010400:Penicillin G / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012877:Skin Manifestations; D013449:Sulfonamides / Q000627:therapeutic use; D014481:United States; D014852:Wales
D013449:Sulfonamides; D010400:Penicillin G; D012293:Rifampin